In SDC, incurable local recurrences and/or distant metastases (R/M) are common and treatment options are limited, especially when human epidermal growth factor 2 (HER2) status is negative or when no other druggable genetic alterations are present in the tumour [3–5]. This evidence concerns the gene ERBB2 and neoplasm.